바카라사이트 벳페어 and WuXi XDC sign business agreement for development of next-generation ADCs

[by Ji, Yong Jun] 바카라사이트 벳페어, a company specializing in antibody drug conjugate (ADC) development, announced on March 12 that it has signed a memorandum of understanding (MOU) with WuXi XDC, a global contract research, development, and manufacturing organization (CRDMO) for ADCs, to collaborate on the development of next-generation ADC therapeutics.

The MOU aims to integrate 바카라사이트 벳페어’ linker platform technology, ‘AbClick,’ with WuXi XDC’s ‘CMC (chemistry, manufacturing, quality control) development platform’ to expedite the development of next-generation ADCs and improve efficiency. Through this collaboration, WuXi XDC will introduce 바카라사이트 벳페어’ AbClick platform and selective drug conjugate technology while offering 바카라사이트 벳페어 the opportunity to expand its global footprint by leveraging WuXi XDC’s extensive global network.

The two companies plan to strengthen their CMC platform capabilities and introduce innovative, cutting-edge solutions in the ADC field. This includes accelerating the 바카라사이트 벳페어 of next-generation ADCs from preclinical candidate selection for global customers and reducing the CMC 바카라사이트 벳페어 timeline.

“This collaboration with 바카라사이트 벳페어 is a strategic partnership that will drive innovation and deliver meaningful value to our customers,” expressed Jimmy Li, CEO of Wuxi XDC. “We believe that the integration of our technologies will offer tailored ADC development solutions to meet our customers’ needs.”

“The synergy between our company’s ADC technology and WuXi XDC’s vast global network and ADC manufacturing capabilities will be substantial,” stated Han Tae-dong, CEO of 바카라사이트 벳페어. “We will take the lead in driving and supporting the development of groundbreaking ADC therapeutics, creating opportunities to benefit patients worldwide,” he added.

On the other hand, 바카라사이트 벳페어 is a company specializing in ADC development, equipped with ‘AbClick,’ a third-generation linker technology that facilitates selective binding to target sites. WuXi XDC is a global firm listed on the Hong Kong Exchanges and Clearing that provides comprehensive services throughout the entire ADC research, development, and manufacturing (CRDMO) process.